Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Obrist

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pathology|June 16, 2006
Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevanceD Fong, M Steurer, P Obrist, et al.
Dento Maxillo Facial Radiology|May 31, 2007
Intraorbital plexiform neurofibroma in an NF-1-negative patientS Jank, E J Raubenheimer, M R Bouckaert, et al.
Gastroenterology|April 21, 2001
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overloadH Zoller, R O Koch, I Theurl, et al.
Cytokine|August 1, 1995
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cellsF A Offner, P Obrist, S Stadlmann, et al.
Gynecologic Oncology|September 1, 1996
Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125A G Zeimet, C Marth, F A Offner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 11, 2006
Tetrahydrobiopterin attenuates microvascular reperfusion injury following murine pancreas transplantationM Maglione, M Hermann, P Hengster, et al.
Heart (British Cardiac Society)|August 18, 2004
Calcium score as assessed by multi-slice computed tomography does not predict maximum plaque burden: an in vitro studyM Frick, F Karakolcu, H Gschnitzer, et al.
Journal of Clinical Pathology|March 30, 2004
Aberrant tetranectin expression in human breast carcinomas as a predictor of survivalP Obrist, G Spizzo, C Ensinger, et al.
Cytokine|July 6, 2000
Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cellsB Abendstein, S Stadlmann, C Knabbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancerM Schmidt, M E Scheulen, C Dittrich, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pathology|June 16, 2006
Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevanceD Fong, M Steurer, P Obrist, et al.
Dento Maxillo Facial Radiology|May 31, 2007
Intraorbital plexiform neurofibroma in an NF-1-negative patientS Jank, E J Raubenheimer, M R Bouckaert, et al.
Gastroenterology|April 21, 2001
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overloadH Zoller, R O Koch, I Theurl, et al.
Cytokine|August 1, 1995
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cellsF A Offner, P Obrist, S Stadlmann, et al.
Gynecologic Oncology|September 1, 1996
Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125A G Zeimet, C Marth, F A Offner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 11, 2006
Tetrahydrobiopterin attenuates microvascular reperfusion injury following murine pancreas transplantationM Maglione, M Hermann, P Hengster, et al.
Heart (British Cardiac Society)|August 18, 2004
Calcium score as assessed by multi-slice computed tomography does not predict maximum plaque burden: an in vitro studyM Frick, F Karakolcu, H Gschnitzer, et al.
Journal of Clinical Pathology|March 30, 2004
Aberrant tetranectin expression in human breast carcinomas as a predictor of survivalP Obrist, G Spizzo, C Ensinger, et al.
Cytokine|July 6, 2000
Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cellsB Abendstein, S Stadlmann, C Knabbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancerM Schmidt, M E Scheulen, C Dittrich, et al.
Pageof 6